Opthea Ltd
F:UKJ2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Opthea Ltd
F:UKJ2
|
AU |
|
Gurit Holding AG
LSE:0QQR
|
CH |
|
S
|
St Galler Kantonalbank AG
LSE:0QQZ
|
CH |
|
F
|
Floor & Decor Holdings Inc
F:1FD
|
US |
|
clearvise AG
F:ABO
|
DE |
|
Jinhe Biotechnology Co Ltd
SZSE:002688
|
CN |
|
A
|
Aalberts NV
LSE:0NX1
|
NL |
|
H
|
Honeywell International Inc
DUS:ALD
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Opthea Ltd (UKJ2)
under the Base Case is
hidden
EUR.
Compared with the current market price of 3 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
UKJ2 Competitors Multiples
Opthea Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Opthea Ltd
F:UKJ2
|
820.8m EUR | -177 469 | 1.9 | 2.1 | 2.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.2B USD | 6 | 87.3 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.1B USD | 4.8 | 22.8 | 16.6 | 16.6 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.4B USD | 5.6 | 19.2 | 12 | 14.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
107.7B USD | 9 | 27.2 | 20.4 | 21.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
74.1B USD | 5.2 | 16.5 | 11.9 | 13.5 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.3B EUR | 11.6 | 37.4 | 40.3 | 41.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
60.2B AUD | 2.7 | 29.5 | 10.1 | 12.7 |